Aroa Biosurgery Ltd Cash Flow-to-Debt Ratio
Aroa Biosurgery Ltd cash flow-to-debt ratio. Aroa Biosurgery Ltd (ARX) has a Cash Flow-to-Debt Ratio of 0.25x as of September 2025, meaning its operating cash flow of AU$3.64 Million could theoretically repay 0% of its total liabilities (AU$14.34 Million) in one year. Check ARX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Aroa Biosurgery Ltd (2014–2025)
Cash flow-to-debt ratio of Aroa Biosurgery Ltd from 2014 to 2025. Historical debt coverage capacity for Aroa Biosurgery Ltd across 12 annual periods. Check ARX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Aroa Biosurgery Ltd Cash Flow-to-Debt Ratio by Year (2014–2025)
Aroa Biosurgery Ltd cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Aroa Biosurgery Ltd. For the full cash flow conversion analysis, see ARX cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.16x | AU$-2.33 Million | AU$14.35 Million | ▲ +64.5% |
| 2024 | -0.46x | AU$-6.76 Million | AU$14.79 Million | ▼ -77.4% |
| 2023 | -0.26x | AU$-3.53 Million | AU$13.69 Million | ▲ +72.8% |
| 2022 | -0.95x | AU$-10.71 Million | AU$11.30 Million | ▼ -267.7% |
| 2021 | -0.26x | AU$-5.01 Million | AU$19.43 Million | ▼ -421.4% |
| 2020 | 0.08x | AU$1.58 Million | AU$19.68 Million | ▲ +32529.9% |
| 2019 | 0.00x | AU$-6.54K | AU$26.44 Million | ▲ +99.9% |
| 2018 | -0.22x | AU$-2.80 Million | AU$12.53 Million | ▲ +92.9% |
| 2017 | -3.14x | AU$-737.06K | AU$234.69K | ▼ -241.4% |
| 2016 | -0.92x | AU$-408.04K | AU$443.57K | ▲ +60.1% |
| 2015 | -2.31x | AU$-1.35 Million | AU$586.00K | ▼ -40.4% |
| 2014 | -1.64x | AU$-1.36 Million | AU$827.00K | — |